Celestica is a electronic component company located in Ontario, Canada, which is part of the Technology sector, and is traded under the ticker CLS on the NYSE exchange.
Celestica stock last closed at $304.29, down 4.42% from the previous day, and has increased 258.16% in one year. It has overperformed other stocks in the Electronic Components industry by 2.27 percentage points. Celestica stock is currently +424.19% from its 52-week low of $58.05, and -16.27% from its 52-week high of $363.40.
There are currently 115.04M CLS shares outstanding. The market cap of CLS is $35.00B. In the past 24 hours, 3.61M CLS shares were traded.
You need an online brokerage account to access the NYSE market and buy CLS stock.
Based on our experience, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you'll need to fill out some personal info so you are able to invest in CLS today.
Now that you've opened your account on investing apps, you can securely and quickly fund your account:
Watch the tutorial below for more details depositing funds into your investment account.
After you have identified the best place to buy Celestica stock, it's important to research their stock prior to buying, so you truly comprehend the risk and opportunity.
WallStreetZen was designed to help average investors do more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on CLS's stock page.
You can use many financial metrics, analyses, models, and charts to gauge CLS's fair value.
Using relative valuations metrics:
You can access additional valuation analysis on CLS's stock here.
Out of 10 sell side analysts who monitor CLS, the consensus analyst rating on Celestica is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
David Vogt, a bottom 18% analyst from UBS maintains CLS with a hold rating and raises their CLS price target from $208.00 to $350.00, on Oct 29, 2025.
Ruben Roy, a top 1% analyst from Stifel Nicolaus reiterates CLS with a strong buy rating and raises their CLS price target from $230.00 to $385.00, on Oct 29, 2025.
Stifel Nicolaus's Ruben Roy raised their price target on Celestica (NYSE: CLS) by 67.4% from $230 to $385 on 2025/10/29. The analyst reiterated their Strong Buy rating on the stock.
Celestica reported its Q3 2025 earnings.
Roy summarized that the quarter was "strong," and that management raised its FY 2025 revenue and EPS guides and initiated a FY 2026 guide.
The analyst noted that leverage is improving modestly for Celestica with more to come longer term.
Overall, Roy called Celestica "a top pick to capitalize on the AI infrastructure build-out."
For Q3 2025, Celestica reported:
Management guided:
For Q4 2025:
For FY 2025:
President & CEO Rob Mionis commented: “We achieved very strong results in the third quarter, with revenue of $3.19 billion and non-GAAP adjusted EPS of $1.58, representing growth of 28% and 52%, respectively, each exceeding the high end of our guidance ranges.
"In the quarter, we achieved strong adjusted operating margin of 7.6%, another high for the company, reflecting the continued strength of our execution.
“Driven by these strong results to date and a demand environment that continues to strengthen, we are pleased to increase our 2025 annual outlook.
"We now expect revenue to reach $12.2 billion, an increase from the prior $11.55 billion, and anticipate non-GAAP adjusted EPS of $5.90, up from our previous estimate of $5.50.
“Furthermore, we are announcing our 2026 annual outlook with revenue of $16.0 billion and non-GAAP adjusted EPS of $8.20, representing growth of 31% and 39% respectively.
"The demand outlook from our largest customers, who continue to make significant investments in AI data center infrastructure, remains strong, supporting our 2026 annual outlook with indications of these dynamics continuing into 2027."
Paul Treiber, a top 7% analyst from RBC Capital maintains CLS with a buy rating and raises their CLS price target from $315.00 to $400.00, on Oct 29, 2025.
Samik Chatterjee, a top 1% analyst from JP Morgan maintains CLS with a strong buy rating and raises their CLS price target from $295.00 to $360.00, on Oct 29, 2025.
An analyst from CiBC maintains CLS with a buy rating and raises their CLS price target from $245.00 to $315.00, on Oct 20, 2025.
You can dig deeper into what analysts are saying on the Celestica stock forecast page.
Last year, CLS earnings were $700.00M. In the last five year, CLS's earnings have gone up by 86.24% per year. This was faster than the Electronic Components industry average of 30.58%.
Last year, CLS revenue was $11.28B. Over the past 5 year, CLS's revenue has gone up by 14.02% per year. This was faster than the Electronic Components industry average of 12.44%.
Learn more about CLS's earnings and revenue performance here.
In the last year, executives and large shareholders at CLS have sold more shares than they have bought.
Mandeep Chawla, Chief Financial Officer of CLS, was the latest CLS insider to sell. They sold $3,762,679.25 worth of CLS stock on Dec 1, 2025.
Dig into more about who owns CLS stock here.
No, Celestica doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two primary order types:
Click the Open button and eToro will place your order.
If you require more info about buying stocks on eToro, click the helpful video below:
Now that you own some CLS stock, you'll want to keep up with your new shares.
Add CLS to a watchlist to keep track of your CLS stock.
To reiterate, here are the 6 steps for buying Celestica stock:
If you are looking for a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Celestica, hit the button below to create your watchlist.